Perrigo announces dismissal of Miconazole patent lawsuit
The dismissal of the lawsuit ends the 30-month Hatch-Waxman stay period, which was originally set to expire in September 2010. Upon receiving final regulatory approval, Perrigo expects to
SK bioscience is set to lead the Gates Foundation-fundedResearch Optimization & Trial Outcome Recommender (ROTOR) project, an AI-based platform aimed at reducing uncertainty in vaccine-development decisions.